Novo Nordisk AS (MEX:NOVOB) Cash Flow for Dividends : MXN-114,763 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Novo Nordisk AS Cash Flow for Dividends?

Novo Nordisk AS's cash flow for dividends for the three months ended in Sep. 2024 was MXN-45,673 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-114,763 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novo Nordisk AS's quarterly payment of dividends declined from Mar. 2024 (MXN-69,089 Mil) to Jun. 2024 (MXN0 Mil) but then increased from Jun. 2024 (MXN0 Mil) to Sep. 2024 (MXN-45,673 Mil).

Novo Nordisk AS's annual payment of dividends increased from Dec. 2021 (MXN-67,072 Mil) to Dec. 2022 (MXN-70,243 Mil) and increased from Dec. 2022 (MXN-70,243 Mil) to Dec. 2023 (MXN-78,893 Mil).

Novo Nordisk AS Cash Flow for Dividends Historical Data

The historical data trend for Novo Nordisk AS's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Cash Flow for Dividends Chart

Novo Nordisk AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-54,448.79

-65,449.02

-67,071.83

-70,242.68

-78,893.45

Novo Nordisk AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow for Dividends	Get a 7-Day Free Trial															-33,478.22	-	-69,089.37	-	-45,673.41

Novo Nordisk AS Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-114,763 Mil.

Novo Nordisk AS Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (MEX:NOVOB) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NOV:Bulgaria NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines